News | Atrial Fibrillation | May 17, 2023

Jasmina Brooks Named President of Biosense Webster

Jasmina Brooks

Jasmina Brooks 


May 17, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmiatreatment and part of Johnson & Johnson MedTech, announced that Jasmina (Jass) Brooks as President, Biosense Webster. In this role, Brooks will have accountability for setting Biosense Webster’s global strategy, and advancing its innovation agenda, to position the organization for continued growth. Brooks succeeds Michael Bodner, Ph.D. who has assumed the role of Global Head of Heart Recovery for Johnson & Johnson MedTech. 

Brooks comes to the role with nearly 25 years of experience in the cardiovascular field, primarily focused on electrophysiology. She is a nine-year veteran of Biosense Webster, and her background is ideally suited to assume leadership of the organization and oversee its next phase of innovation and growth.  

Most recently, Brooks was Vice President, Global Strategic Marketing, Biosense Webster. In this role, she worked with cross-functional and international teams to set the strategy and shape the company product pipeline to drive growth, market share, and profitability. Brooks joined Biosense Webster in 2014 and held positions of increasing scope and responsibility in the Global Strategic Marketing Organization. Prior to joining Johnson & Johnson, Brooks spent 15 years at GE Healthcare, where she held various roles in commercial marketing, global strategic marketing, product development and engineering in the US and EMEA. Brooks holds a Bachelor of Science in Biomedical Engineering from Louisiana Tech University.  

“Jass Brooks is a well-respected, collaborative leader with a deep knowledge of the electrophysiology space, a track record of successfully driving growth and market leadership, as well as a deep commitment to developing talent and fostering a culture of collaboration and inclusivity,” said Celine Martin, Company Group Chairman, Cardiovascular & Specialty Solutions Group, Johnson & Johnson. “Jass has dedicated her career to championing excellence in patient outcomes and solving unmet medical needs, and she will continue to harness this passion in leading Biosense Webster as the company advances innovation solutions to help people with Afib live the lives they want.”  

“It is an honor to lead Biosense Webster, with its proud legacy and unmatched capabilities in cardiac catheter ablation,” said Brooks. “I look forward to continuing to partner closely with the electrophysiology community to elevate standards of care in AFib.” 

For more information: www.biosensewebster.com 


Related Content

Feature | Cardiovascular Business

May 24, 2023 — Park Ridge, N.J.-based publisher Wainscot Media has named Laura Dowden as managing director, group ...

Home May 24, 2023
Home
News | Cardiovascular Business

May 3, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) Board of Directors is proud to announce that ...

Home May 03, 2023
Home
News | Cardiovascular Business

May 2, 2023 — Auburn Community Hospital (ACH) announced today that Dr. Ronald L. Kirshner has been appointed Chair and ...

Home May 02, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

As we head into Spring, let's take a look at the Top 10 topics that viewers were reading about during the month of April ...

Home May 01, 2023
Home
Feature | Cardiovascular Business | By Emily Gilbert and Kamran Zamanian, PhD

The European interventional cardiology device market is one of the larger markets in the global space. The market is ...

Home April 24, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

In the blink of an eye yet another month has passed, and here is a look at the Top 10 of what DIcardiology.com viewers ...

Home April 03, 2023
Home
News | Cardiovascular Business

March 29, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

Home March 29, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

Home March 01, 2023
Home
News | Cardiovascular Business

February 17, 2023 — Internationally recognized cardiologist in heart transplantation Jon Kobashigawa, MD, director of ...

Home February 17, 2023
Home
News | Cardiovascular Business

February 9, 2023 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has entered into a long ...

Home February 09, 2023
Home
Subscribe Now